Video

Dr. Eskander on the Utility of Lymphadenectomy in Endometrial Cancer

Ramez N. Eskander, MD, discusses the utility of lymphadenectomy in patients with endometrial cancer.

Ramez N. Eskander, MD, assistant professor and gynecologic oncologist at UC San Diego Health, member of the Gold Humanism Honor Society, the Society of Gynecologic Oncology, and the American Society of Clinical Oncology, discusses the utility of lymphadenectomy in patients with endometrial cancer.

Lymphadenectomies are utilized to determine the prognosis and stage of patients with endometrial cancer; it is not intended to provide a survival advantage, according to Eskander. Sentinel lymph node assessments are used to identify the presence of positive lymph nodes, which will help determine whether a patient will derive more benefit from systemic chemotherapy or radiation plus chemotherapy, Eskander explains. If sentinel lymph node mapping is unsuccessful, a side-specific comprehensive lymphadenectomy is needed, Eskander says.

In patients who receive imaging prior to surgery, and are found to have grossly positive lymph nodes, resection of these lymph nodes is not in the context of a staging lymphadenectomy, Eskander says. In these cases, lymphadenectomy is utilized to resect grossly positive disease in an attempt to improve outcomes, Eskander concludes.

Related Videos
Jonathan Spicer, MD, PhD, FRCS
Daniel DeAngelo, MD, PhD
Marc J. Braunstein, MD, PhD, associate professor, Department of Medicine, co-director, Hematology-Oncology System, New York University (NYU) Grossman Long Island School of Medicine
Douglas W. Sborov, MD, MS, associate professor, Department of Internal Medicine—Division of Hematology and Hematologic Malignancies; director, Hematology Disease Center and Plasma Cell Dyscrasias Program, the University of Utah Huntsman Cancer Institute
Bradley C. Carthon, MD, PhD
David C. Fisher, MD
Alan Tan, MD
Binod Dhakal, MD
Sheldon M. Feldman, MD
Yair Lotan, MD, UT Southwestern Medical Center